Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Teva Pharmaceutical Industries Ltd. announced that the U.S. Court of Appeals for the Federal Circuit unanimously affirmed a September 2007 ruling, which denied a motion filed by Wyeth and Altana for a preliminary injunction related to Teva's Pantoprazole Sodium Delayed Release (DR) Tablets, AB-rated to Wyeth's Protonix DR Tablets.

Today in Regulatory Issues...keeping you current

The Unintended Consequences of Clinical Trials Regulations
PLoS Medicine, 12/04/09

Mandatory Disclosure of Pharmaceutical Industry-Funded Events for Health Professionals
PLoS Medicine, 12/02/09

FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation
International Journal of Electronic Healthcare , 12/01/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address